Skip to content

Clinical trials

Diabetes Mellitus, Type 1 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Country / region: Australia Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20024
20032
20043
20051
20063
20075
20083
20092
20102
20111
20121
20133
20144
20154
20162
20173
20192
20202
20212
20221
20235
20241
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Recruiting9
Active, not recruiting6
Terminated5
Not yet recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S12
Eli Lilly and Company8
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
Medtronic MiniMed, Inc.4
AstraZeneca3
Melbourne Health3
Sanofi3
Boehringer Ingelheim2
St Vincent's Hospital Melbourne2
Bayhill Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 170
Diabetes Mellitus17
Diabetes Mellitus, Type 29
Autoimmune Diseases3
Diabetic Nephropathies3
Diabetic Neuropathies2
Endocrine System Diseases2
Glucose Metabolism Disorders2
Hypoglycemia2
Kidney Failure, Chronic2

Trials

Showing 51 to 70 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.